Since July 1, 2019, Regulation (EC) No. 469/2009 concerning the supplementary protection certificate (SPC) for medicinal products has been amended to allow manufacturers of generics and biosimilars established in the European Union (EU) manufacture in the EU products, or medicines containing these products, for export to third countries outside of the EU, or for storage in the 6 months preceding SPC expiry.
Discover an article from Camille PECNARD and Alix CAPELY : overview of case law on the collection of evidence in IP cases in France.
5 - 6 April 2018
Meet Camille PECNARD and Pierre-Emmanuel MEYNARD (French attorneys-at-law) during the 23rd European Forum of Intellectual Property organised by UNIFAB in Paris on the following theme: "What new tools, what original ways, what unusual actors to protect intelligence?".
Compulsory registration via UNIFAB.
Since July 1, 2019, Regulation (EC) No. 469/2009 concerning the supplementary protection certificate (SPC) for medicinal products has been amended to allow manufacturers of generics and biosimilars established in the European Union (EU) manufacture in the EU products, or medicines containing these products, for export to third countries outside of the EU, or for storage in the 6 months preceding SPC expiry.
The European Patent Office have amended the Guidelines for Examination. The new Guidelines are valid as of November 2019. They include many minor editorial changes but also other changes, which may have an influence on the proceedings at the EPO. In the following, we have selected some of these changes.
PPH programme with Superintendence of Industry and Commerce of Columbia extended. The European Patent Office has extended the PPH programme with the Superintendence of Industry and Commerce of Columbia (SIC). The trial period for this programme, which was initially set up for three years from 1st of October 2016, has been extended for a further three year period until 30 September 2022.
Discover an article from Camille PECNARD and Alix CAPELY : overview of case law on the collection of evidence in IP cases in France.
La revue de référence internationale a publié son classement 2018 : LAVOIX se place dans le TOP-ONE pour le contentieux en Brevets et en Marques.
Pour la 7e année consécutive LAVOIX dévoile les résultats 2018 de son baromètre de la Propriété Intellectuelle. Etude menée auprès des responsables PI (372 répondants cette année), elle permet ainsi chaque année d’apporter un éclairage sur le rôle, la stratégie, l’activité, mais aussi les investissements, les enjeux et perspectives de la PI au sein des entreprises et des organismes de recherche ou d’animation économique français.
5 - 6 April 2018
Meet Camille PECNARD and Pierre-Emmanuel MEYNARD (French attorneys-at-law) during the 23rd European Forum of Intellectual Property organised by UNIFAB in Paris on the following theme: "What new tools, what original ways, what unusual actors to protect intelligence?".
Compulsory registration via UNIFAB.
16 April 2018
Pierre-Emmanuel MEYNARD, Attorney-at-law since 2014, will be attending the Young EPLAW Congress (European Patent Lawyers Association), in Brussels, Belgium. This event is a unique opportunity to meet young lawyers from all over Europe and discuss European patent law.
26 - 27 April 2018
Meet Anne FRANCASTEL, European patent attorney, at the VPP Spring meeting, Association of Intellectual Property Experts, in Stuttgart, Germany.
The LAVOIX group is constantly growing and always looking for new collaborators.
oUR JOB OFFERSStudents, recent graduates, join us
Certification ISO 9001:2015 applicable to all the IP attorney activities and for all its offices. 
Download the presentation
